Pasithea Therapeutics (KTTA) Goodwill & Intangibles (2022 - 2026)
Pasithea Therapeutics recorded quarterly Goodwill & Intangibles of $3.6 million in Q1 2026, down 4.17% quarter-over-quarter from $3.8 million in Q4 2025, and down 56.95% year-over-year from $8.4 million in Q1 2025.
Pasithea Therapeutics' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 56.95% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (down 56.95% YoY), while the FY2025 annual figure was $3.8 million, down 61.55% from the prior year.
- Goodwill & Intangibles came in at $3.6 million for Q1 2026 at Pasithea Therapeutics, down from $3.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $9.8 million in Q4 2022 to a low of $3.6 million in Q1 2026.
- A 5-year average of $7.8 million and a median of $9.0 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles soared 148.32% in 2023 and plunged 61.55% in 2025, its largest moves.
- Pasithea Therapeutics' Goodwill & Intangibles stood at $9.8 million in 2022, then fell by 6.41% to $9.2 million in 2023, then gained by 6.85% to $9.8 million in 2024, then tumbled by 61.55% to $3.8 million in 2025, then fell by 4.17% to $3.6 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $3.6 million, $3.8 million, and $8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 8.10 Mn |
| Jun 30, 2025 | 9.83 Mn |
| Mar 31, 2025 | 8.42 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 30, 2024 | 8.73 Mn |
| Jun 30, 2024 | 9.83 Mn |
| Mar 31, 2024 | 9.83 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Sep 30, 2023 | 9.36 Mn |
| Jun 30, 2023 | 9.52 Mn |
| Mar 31, 2023 | 9.68 Mn |
| Dec 31, 2022 | 9.83 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 3.83 Mn |